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High-resolution cryo-EM structures of respiratory 
complex I: Mechanism, assembly, and disease
Kristian Parey1,2,3, Outi Haapanen4, Vivek Sharma4,5, Harald Köfeler6, Thomas Züllig6, 
Simone Prinz2, Karin Siegmund1,3, Ilka Wittig7, Deryck J. Mills2, Janet Vonck2, 
Werner Kühlbrandt2, Volker Zickermann1,3*
Respiratory complex I is a redox-driven proton pump, accounting for a large part of the electrochemical gradient 
that powers mitochondrial adenosine triphosphate synthesis. Complex I dysfunction is associated with severe 
human diseases. Assembly of the one-megadalton complex I in the inner mitochondrial membrane requires 
assembly factors and chaperones. We have determined the structure of complex I from the aerobic yeast Yarrowia 
lipolytica by electron cryo-microscopy at 3.2-Å resolution. A ubiquinone molecule was identified in the access 
path to the active site. The electron cryo-microscopy structure indicated an unusual lipid-protein arrangement at 
the junction of membrane and matrix arms that was confirmed by molecular simulations. The structure of a 
complex I mutant and an assembly intermediate provide detailed molecular insights into the cause of a hereditary 
complex I–linked disease and complex I assembly in the inner mitochondrial membrane.
INTRODUCTION
NADH:ubiquinone oxidoreductase (complex I), one of the largest 
membrane protein complexes known, plays a central role in aero-
bic energy metabolism (1). Redox-linked proton translocation by 
complex I generates ~40% of the proton motive force that drives 
adenosine triphosphate synthesis. Complex I dysfunction is asso-
ciated with a wide range of neuromuscular and neurodegenerative 
diseases (2). Reverse electron transfer at complex I during ischemia/
reperfusion releases toxic reactive oxygen species (ROS) (3). The phys-
iologically important active-deactive (A/D) transition of complex I 
(4) is thought to counteract ROS-linked reperfusion injury. Struc-
tures of bacterial and mitochondrial complex I have been determined 
by x-ray crystallography or, more recently, by electron cryo-microscopy 
(cryo-EM) at increasing resolutions (5, 6). Previously, we have re-
ported the x-ray (7) and cryo-EM (8) structure of complex I from 
the aerobic yeast Yarrowia lipolytica, a model organism for eukaryotic 
complex I and complex I–linked diseases, at ~3.8- and 4.3-Å resolu-
tion. The arrangement of 14 central subunits in the L-shaped assem-
bly, consisting of a membrane arm and a matrix arm, is conserved 
from bacteria to man. The matrix arm is divided into the N module 
for NADH (reduced form of nicotinamide adenine dinucleotide) 
oxidation and the Q module for ubiquinone (Q) reduction. The po-
sition of the Q reduction site ~20 Å above the membrane surface and 
its connection to the membrane bilayer by an access tunnel were 
unexpected. There is general agreement that Q reduction drives pro-
ton translocation, but the mechanism of long-range energy transfer 
from the Q reduction site to the proton pumping sites in the mem-
brane arm remains unclear. We proposed that Q reduction gener-
ates the power stroke in the complex I catalytic cycle by a concerted 
rearrangement of three loops in the Q binding site and the interface 
region of the membrane and matrix arms (7, 8). Recent experiments 
demonstrated that movement of the long loop connecting trans-
membrane helices (TMHs) 1 and 2 of subunit ND3 is required to 
drive proton translocation (9).
In mammalian complex I, the core of central subunits is sur-
rounded by 31 accessory subunits. The function of most accessory 
subunits is unknown, but NDUFS4 was identified as critical for patho-
genic mutations that cause Leigh syndrome, a serious neurological 
disorder (10). Various Ndufs4 knockout mouse models were generated 
to study the physiology of complex I dysfunction but have failed to 
clarify the molecular basis of the disease (11). NDUFS4 stabilizes 
the N module (12) and is thought to play a role in complex I assembly 
linked with the assembly factor NDUFAF2. NDUFAF2 is a paralog 
of accessory subunit NDUFA12 (13). Its expression is regulated by 
cytokines and mutations in the NDUFAF2 gene that cause progres-
sive encephalopathy (13). However, the structure of NDUFAF2 and 
how it interacts with complex I assembly intermediates was unknown 
until now. We now combine the power of cryo-EM, yeast genetics, 
and large-scale computer simulations to explore the structure and 
mechanism of complex I, the structural basis of NDUFS4-linked 
Leigh syndrome, and the role of assembly factor NDUFAF2 in the 
complex I assembly.
RESULTS AND DISCUSSION
Structure determination
Respiratory complex I from the aerobic yeast Y. lipolytica isolated in 
the detergent lauryl maltose neopentyl glycol (LMNG) was highly 
active (19.7 mol NADH min−1 mg−1). LMNG preserved activity 
much better than dodecyl maltoside (DDM), as reported for the 
ovine complex I (14). Single-particle cryo-EM yielded a 3.2-Å map 
(figs. S1 and S2, table S1, and movie S1), which enabled us to build a 
model containing 8057 of the 8300 residues, all cofactors, and 33 lipid 
molecules (Fig. 1). The model includes nearly all the regions that 
were unresolved or modeled as polyalanine in our previous cryo-EM 
structure (8). The high resolution permitted us to define the position 
of subunit NUUM unambiguously (fig. S3, E and F) and to identify 
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YALI1_D30003p as the last missing protein component of Y. lipolytica 
complex I (fig. S3C). The new NIGM subunit is an ortholog of NDUFB2 
in mammalian complex I and resides at the distal tip of the mem-
brane arm (fig. S3, D and E). Complex I of Y. lipolytica, thus, consists 
of 43 subunits. Subunits NUXM, NUUM, and ST1 clearly have no 
equivalent in the mammalian complex I (table S2). For ease of compar-
ison with other complex I structures (see table S2), we have adopted the 
subunit nomenclature for human complex I wherever possible.
A second Q binding site
The preparation for cryo-EM contained 82.8 lipids and 1.9 Q9 mole-
cules per complex I, as determined by quantitative mass spectrometry 
(fig. S4D and table S3). Q is reduced by terminal FeS cluster N2 that 
resides in the subunit NDUFS7 (6–8). The buried position of N2 
requires a tunnel that provides access to Q from the hydrophobic 
bilayer core to the center of the matrix arm. The entrance to the 
extended access pathway is framed by TMHs 1 and 6 and the trans-
verse helix 1 of subunit ND1. A clear density indicates a bound Q 
molecule in the tunnel (Fig. 2 and fig. S4C). At a center-to-center 
distance of 26.7 Å to FeS cluster N2, the head group is surrounded 
by a network of charged residues of ND1 and NDUFS7. Ile106NDUFS7 
points to the center of the Q head group, providing hydrophobic 
interactions. In a recent study, exchange of this residue for alanine or 
phenylalanine decreased ubiquinone reductase activity (15). Several 
residues of TMHs 1 and 6 and of surface helix 1 of ND1 are in con-
tact with the first four isoprenoid units of the Q tail. To explore the 
dynamics of protein Q interactions, we performed atomistic classi-
cal molecular dynamics (MD) simulations of the entire complex I 
structure in a membrane-solvent environment (fig. S5A). The Q bind-
ing pocket rapidly filled with water, and the Q head group engaged 
in tight hydrogen bonding interactions with three to four water 
molecules (fig. S5, B and C). In contrast, the isoprenoid units of Q 
interacted with nonpolar amino acid residues (fig. S6), in agreement 
with the cryo-EM structure (Fig. 2).
A tightly bound Q in complex I had been proposed earlier on the 
basis of biochemical data (16), and in our lower-resolution maps, we 
had identified a conspicuous nonprotein density in the Q tunnel (8). 
The strong density we observe in our present high-resolution map 
indicates firm binding and significant occupancy of the site by a Q 
molecule. The second Q molecule indicated by the near 2:1 stoichi-
ometry was not identified in the map, most likely because it is dis-
tributed over a number of different low-occupancy sites. However, 
we cannot exclude that it is randomly distributed in the detergent 
micelle. The Q binding site in our cryo-EM structure matches a bind-
ing position in the extended Q tunnel predicted by molecular simu-
lations (17, 18). It is different from the Q reduction site near the FeS 
cluster N2 characterized in our previous work (8) and appears to 
represent a “stepping stone” for a substrate molecule on its way be-
tween the active site and the lipid bilayer (Fig. 2). While substrate 
exchange with the Q pool in the membrane must be possible on a 
short time scale, occupancy of the observed site indicates that an en-
ergy barrier restricts diffusion from the tunnel into the membrane. 
Considering the length of the access pathway and the restricted mo-
bility in the tunnel, the height of the energy barrier (17) is a critical 
parameter for complex I turnover. As an alternative to a substrate 
molecule traveling the complete length of the access path in each 
reaction cycle, a bound Q molecule might act as a mobile carrier 
shuttling electrons between the Q reduction site near N2 and another 
site in the tunnel, from where it could transfer electrons to a Q mol-
ecule of the membrane Q pool at the protein-lipid interface (19). 
However, extended site-directed mutagenesis of the Q binding pocket 
and kinetics measured with different short-chain Q analogs suggest 
that added substrate molecules are directly reduced by cluster N2, 
which would argue against a shuttle mechanism involving a bound Q 
(20). Moreover, there are no robust structural or biochemical data 
supporting a Q binding site on the surface of ND1. Such a site would 
be required to enable electron transfer between the shuttling and sub-
strate Q molecules. In any case, tight binding of a Q molecule at some 
distance from the Q reduction site is unexpected. The functional 
significance of the observed site in the catalytic cycle of complex I 
will be evaluated in future work.
Complex I lipids
We found clear density for 8 phosphatidylcholine, 15 phosphatidyl-
ethanolamine, 6 cardiolipin (CL), 4 phosphatidylinositol, and 2 de-
tergent molecules that were built into the map (Figs. 1 and 3A and 
fig. S2). A comparison with lipid binding sites in mouse (21) and ovine 
(14) complex I is shown in fig. S7. Matrix arm subunits NDUFA9, 
Fig. 1. Cryo-EM structure of respiratory complex I from Y. lipolytica. (A) Side view; 
inset shows FMN and FeS clusters [assignment of EPR signatures N1 to N5 according 
to (72)] and a Q molecule in the access pathway. (B) Top view with the matrix arm 
omitted for clarity and lipid molecules (yellow) and Q molecule (green) in sphere 
representation.
 o
n
 July 23, 2020
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Parey et al., Sci. Adv. 2019; 5 : eaax9484     11 December 2019
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
3 of 10
NDUFS7, and NDUFA12 together bind the head groups of six lipid 
molecules. The head groups in this lipid cluster form a plateau that is 
out of plane with lipids in the central part of the membrane arm, in-
dicating a local deformation of the planar bilayer geometry (Fig. 3A). 
The N-terminal helix 1 of subunit NDUFS7 at the center of the pla-
teau is positioned directly above the entrance to the Q tunnel (fig. S8A), 
suggesting that modulation of the membrane surface might facili-
tate the access of substrate Q from the membrane. Two lipids flank-
ing this helix were also observed in the structure of complex I from 
mouse (fig. S7) (21). The matrix arm/membrane arm interface is lined 
by eight amphipathic helices of central and accessory subunits (fig. 
S8B). A CL binding site between amphipathic helices from NDUFS8, 
NDUFA12, and NDUFA7 is consistently observed in mouse, ovine, 
and yeast complex I (14, 21). Overall, lipid tails in the interface region 
are in a notably tilted orientation. In our atomistic simulations, lipids 
in this region showed a clear tendency toward a horizontal orienta-
tion, in agreement with the cryo-EM structure (Fig. 3B and fig. S9, 
A and B). Typically, lipid tails close to the protein surface in this re-
gion deviated by 50° to 90° from the membrane normal (fig. S9). The 
tilt of lipid fatty acid chains was much more pronounced in the ma-
trix leaflet and resulted in a local thinning of the membrane in the 
interface region (Fig. 3 and fig. S9). Adsorption of an amphipathic 
helix to a membrane surface can distort the default geometry of a 
lipid bilayer (22). The peptide displaces the lipid head groups and 
thereby destabilizes the lipid tail region (fig. S9D). The lipid tails in 
the destabilized region tend to wrap around the hydrophobic face of 
the amphipathic helix, reducing the thickness of the lipid bilayer lo-
cally. The effect on the lipid head groups exerted by the amphipathic 
helices in the membrane arm/matrix arm junction is enhanced by 
the tilted TMHs of ND1 and adjacent accessory subunits NDUFA1 
and NDUFA13 (fig. S9B). The local membrane thinning by up to 10 Å 
could help to guide Q to the entry portal of the access pathway in 
ND1 (Fig. 3B). Considering that complex III oxidizes Q on the dis-
tal side of the membrane, we propose that the thinner lipid bilayer 
reduces the energy barrier for flipping the polar Q head group from 
one leaflet to the other, which would be required for fast alternate 
access to the active sites of respiratory chain complexes I and III (23).
Active and deactive complex I
Complex I from mammals or the yeast Y. lipolytica undergoes a re-
versible transition between an active A form and a deactive D form 
(4, 24). In the absence of substrate, the A form spontaneously con-
verts to the D form. The D form is stabilized by divalent cations and 
is arrested irreversibly upon modification of a cysteine residue in 
subunit ND3 by the sulfhydryl reagent N-ethylmaleimide (NEM) 
(25). Only the D form is sensitive to NEM. The conversion from D 
to A is induced by addition of the substrates NADH and oxidized 
Q. Bovine complex I was isolated as a mixture of A and D forms that 
gave rise to different three-dimensional (3D) classes in the cryo-EM 
analysis (26). By contrast, the Y. lipolytica complex yielded only one 
major 3D class (fig. S1) that we assign to the D form based on its 
reactivity toward Mg2+ or NEM (fig. S10).
Two alternative models, the “blocked Q site model” and the “un-
folded Q site model,” were recently developed for structural changes 
associated with the A/D transition of complex I (7, 27). The blocked 
Q site model proposed that Q access to its reduction site is restricted 
in the D form by the loop connecting the first two  strands of the 
N-terminal  sheet of NDUFS2 (7). However, the conformation of 
the complete 1-2 loop in our present cryo-EM structure is different 
and matches that of the corresponding loop in the murine A form 
(21) almost perfectly (fig. S11A). Therefore, it seems unlikely that 
the difference between A and D is due to conformational changes 
of the 1-2 loop in the NDUFS2 subunit, rendering the blocked Q 
site model obsolete. The different loop conformation observed in 
Y. lipolytica complex I by x-ray crystallography and cryo-EM may be 
due to the different detergents used for protein purification (fig. S11B). 
The alternative unfolded Q site model suggested that the D form of 
mammalian complex I is distinguished by disordered loops in the Q 
binding pocket and surrounding protein structure (21, 27). The un-
folded Q site model does not apply to Y. lipolytica complex I because 
we observe side-chain densities for nearly all the loop regions that 
were disordered in the D form of murine or bovine complex I (fig. S11, 
C and D). The resolved regions include the TMH 5/6 loop of ND1, 
the TMH 1/2 loop of ND3, the 1-2 loop of the NDUFS2, and the 
C-terminal domain of NDUFA9. The major structural rearrangement 
in mammalian complex I reflects a high-energy barrier between the A 
and D forms (24). This barrier is much lower in the yeast complex 
(24), which would require a less extensive conformational change. 
Restructuring of the Q binding site in mammalian complex I was sug-
gested to be induced by substrate binding (27). The observed Q mole-
cule at the entrance of the Q binding pocket might stabilize this 
region in the D form of the yeast enzyme.
Fig. 2. Q molecule in the access pathway. (A) Slice of membrane arm/matrix arm interface viewed from the back of complex I, a cavity (gray) opens in ND1 and permits 
access of Q from the bilayer to the Q reduction site near cluster N2. (B) Selected residues near the Q binding site (density map drawn at 1.0  contour level in blue mesh; 
Q molecule, green sticks) (see fig. S4).
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Structure of a complex I mutant without the disease-related 
accessory subunit NDUFS4
The accessory subunits (fig. S3, A and B) are generally thought to be 
dispensable for the core function of complex I because they are not 
present in the simplest 14-subunit “minimal” prokaryotic complex I. 
However, orthologs of accessory subunits NDUFS4, NDUFS6, 
and NDUFA12 were identified as components of complex I in 
-proteobacteria, which are thought to be the ancient predecessors of 
mitochondria (28). In eukaryotes, NDUFS4, NDUFS6, and NDUFA12 
act together in the final step of complex I assembly (29). Different 
types of mutations in the gene encoding NDUFS4 have been found 
to cause Leigh syndrome (10). Our yeast genetic model system enables 
us to study the structural basis of NDUFS4-linked Leigh syndrome 
in detail. In a Y. lipolytica ndufs4 strain, complex I levels dropped to 
~40% of wild type, indicating a less efficient assembly process, and 
complex I lacking NDUFS4 was associated with the assembly factor 
NDUFAF2 (12). However, NDUFAF2 was lost during protein puri-
fication in detergent, suggesting weak interaction. Biochemical and 
spectroscopic analysis of the mutant complex indicated reduced elec-
tron transfer activity, increased ROS production, and prominent 
changes in the electron paramagnetic resonance (EPR) spectra of 
FeS clusters N1b and N3 (12).
We determined the cryo-EM structure of the mutant complex I 
at 4.0-Å resolution (Fig. 4, fig. S1, and movie S2) in DDM and com-
pared it to the present wild-type structure presented here and to our 
recent 4.3-Å cryo-EM map of complex I in the same detergent (8). The 
mutant structure contains all complex I subunits except NDUFS4. 
Despite changes in the EPR spectrum, there is no indication of a loss 
or major change in position of any of the eight FeS clusters. The binu-
clear FeS cluster N1b is located at the bottom of a cleft of NDUFS1 
that is traversed by a C-terminal section of NDUFS4 (Fig. 4). The 
C-terminal end of NDUFS4 runs along the interface of N-module 
subunits NDUFS1, NDUFV1, and NDUFV2. The C-terminal residue 
Lys161 of NDUFS4 points toward cluster N3 in NDUFV1. In the ab-
sence of NDUFS4, both cluster binding sites are exposed and solvent 
accessible (Fig. 4D). To analyze this in more detail, we performed 
solvent-accessible surface area (SASA) calculations on the cryo-EM 
structures and found that the (~7 Å) region around clusters N3 and 
N1b is more exposed to solvent by ~87 and 228 Å2, respectively, in 
mutant than in wild type. Similarly, an increase in surface area is also 
observed for subunits NDUFS1 and NDUFV1 by ~1935 and ~487 Å2, 
respectively, in the complex I lacking NDUFS4 (see the section on 
“Computational methods”). The change in chemical environment 
explains both the different EPR spectra and the increased ROS for-
mation and decreased electron transfer activity of the mutant complex. 
Fig. 3. Lipid binding sites and unique protein lipid arrangement at the junction 
of the membrane and matrix arms. (A) Lipid and detergent binding sites in the mem-
brane arm. CL, cardiolipin; PC, phosphatidylcholine; PE, phosphatidylethanolamine; 
PI, phosphatidylinositol. (B) Cross section of a simulation snapshot reveals that the 
lipid bilayer thickness is reduced by ~10 Å in the vicinity of protein, apparently due 
to the unusual local protein architecture. Q is shown as spheres colored by atom 
(carbon, green; oxygen, red). Lipids in the two leaflets are colored by lipid type. PC/
PE/CDL in the matrix leaflet are shown in shades of pink, and those in the other 
leaflet in shades of blue. Highly bent lipid tails next to protein are drawn as sticks. 
Subunits are colored as in Fig. 1, and accessory subunits are gray.
Fig. 4. Mutant lacking NDUFS4. (A) Overlay of wild type (gray, NDUFS4 green 
surface representation) and mutant (cartoon, color as in Fig. 1). (B) Zoom into mem-
brane arm. Disordered protein in the mutant is highlighted by color. (C) Overlay of 
NDUFS4 on the matrix arm of the mutant. (D) FeS clusters N1b and N3 in the mutant 
are more exposed to solvent than in the fully assembled complex (see main text).
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Previous studies with patient material had suggested that complete 
absence of the N module is a typical characteristic of NDUFS4-linked 
Leigh syndrome and a valuable diagnostic marker in BN-PAGE 
(blue native polyacrylamide gel electrophoresis) analysis (30). Our 
wild-type structure shows that NDUFS4 is an important connecting 
element in the matrix arm. In the mutant, domains of NDUFV1, 
NDUFV2, NDUFS1 and the attached accessory subunit NDUFA2 
are tilted backward by 1°. However, the N module was not lost during 
protein purification. The N module is unlikely to detach in vivo 
because intact tissue of Ndufs4 knockout mice exhibited up to 50% 
of wild-type levels of rotenone-sensitive oxygen consumption (31), 
in agreement with our activity measurements (12).
Structural changes in the mutant are not limited to the vicinity of 
NDUFS4 in the matrix arm. The hydrophobic accessory subunit 
NDUFA11 in the center of the membrane arm shields the C-terminal 
membrane anchor of the long lateral helix of ND5 (Fig. 4B). In the 
mutant, density for the N-terminal half of NDUFA11, for the end of 
the lateral helix, and for part of the following TMH 16 of ND5 is 
weak or absent, indicating disorder. Moreover, structural integrity 
of TMH 4 and adjacent loops of ND6 and the long N-terminal 
extension of NDUFS2 on the surface of the membrane arm is com-
promised. The same changes were observed in two independent 
preparations of the mutant but not in the wild-type control. To address 
the functionality of the membrane arm, we measured proton trans-
location of the mutant after reconstitution into lipid vesicles. ACMA 
(9-amino-6-chloro-2-methoxyacridine) quenching was slower but 
reached the same level as the wild-type control, indicating that the 
mutant retained most of its proton pumping capacity, albeit at a 
slightly reduced rate (fig. S12). Distortion of NDUFA11 and the 
protein structure around it is in line with the observation that super-
complex formation stabilizes the NDUFS4 mutant in a mouse model 
of Ndufs4-linked complex I dysfunction (32). In complex I super-
complexes, NDUFA11 interacts with three subunits of complex III 
(33). We propose that binding to complex III mitigates structural 
disorder in the membrane arm, which would at least partially rescue 
the function of the mutant complex.
NDUFS4-linked Leigh syndrome is thus caused by a combina-
tion of impaired complex I assembly and changes in the structure of 
assembled mutant complex I. Specifically, absence of NDUFS4 dis-
torts two of the FeS cluster binding sites in the N module and parts 
of the membrane arm. Compromised NADH dehydrogenase func-
tion interferes with mitochondrial energy metabolism and decreases 
the NAD+/NADH ratio, which triggers secondary effects including 
lactic acidosis. ROS are released at compromised cluster binding 
sites or because electrons are trapped at the flavin site and might 
cause further decay of mitochondrial functions in the mutant.
Cryo-EM structure of a complex I assembly intermediate
In contrast to the mutant lacking NDUFS4, deletion of the gene for 
accessory subunit NDUFS6 in Y. lipolytica resulted in the accumula-
tion of a complex I assembly intermediate that tightly bound assembly 
factor NDUFAF2 but lacked accessory subunits NDUFS6 and NDUFA12 
(34). Mutations in the NDUFS6 gene cause lethal neonatal deficiency 
in human complex I (35). Reintroduction of NDUFS6 by in vitro 
import into patient mitochondria lifted a block in the assembly pro-
cess and facilitated formation of complete complex I from an inter-
mediate harboring assembly factor NDUFAF2 (36).
NDUFA12 and NDUFAF2 are paralogs and share a longer 
N-terminal and a shorter C-terminal region of similar sequence, in-
terrupted by a stretch of sequence in the assembly factor (fig. S13) 
(37). We isolated the NDUFAF2 assembly intermediate in LMNG 
and determined its structure at 3.3-Å resolution by cryo-EM (Fig. 5, 
fig. S1, and movie S3). Overall, the structure matched the fully 
assembled complex I, but a major part of the matrix arm was tilted 
sideways (Fig. 5B), resulting in a 6-Å displacement at the tip of the 
N module. At the position occupied by the N-terminal core domain 
of NDUFA12 in wild-type complex I, we modeled the corresponding 
domain of NDUFAF2 in the assembly intermediate (Fig. 5 and fig. 
S13). The resulting structure clearly proves that in the fully assem-
bled complex, NDUFA12 replaces NDUFAF2, as proposed on the 
basis of evolutionary correlation (37). The next part of the assembly 
factor folds into a long helix pointing toward the distal part of the 
matrix arm (Fig. 5 and fig. S13). In an overlay with the wild-type 
structure, this helix clashes with the position of a loop that connects 
the two major domains of subunit NDUFS6. Therefore, NDUFAF2 
prevents binding of NDUFS6 while it occupies the NDUFA12 position. 
The extensive interaction between NDUFA12 and NDUFS6 implies 
that these two subunits operate as one unit. Residues 122 to 223 of 
NDUFAF2 are not resolved, but the C terminus binds to subdomains 1 
and 2 of the large C-terminal domain of NDUFS1. In native com-
plex I, the C terminus of NDUFA12 binds in the same position (Fig. 5).
In the assembly intermediate, density extending along the inter-
face region including the C-terminal part of subunit NDUFA9, the 
long TMH 1/2 loop of ND3, and a large part of NDUFA7 is poorly 
ordered or absent (fig. S8C). The N- and C-terminal helices of 
NDUFS7 are shifted, and lipids in the interface region are un-
resolved, in contrast to lipids in the major part of the membrane arm. 
The Q content of the preparation is only 0.5 nmol per nmol complex I 
as determined by quantitative mass spectrometry. There is no density 
Fig. 5. Cryo-EM structure of a complex I assembly intermediate. (A) Overlay of 
wild type (gray) and assembly intermediate (color) with assembly factor NDUFAF2 
(purple surface). (B) Overlay as in (A) viewed from the back. The arrow indicates the 
tilted matrix arm. (C) Membrane arm/matrix arm interface of wild-type complex I 
viewed as in (B) with NDUFA12 and NDUFS6 highlighted. (D) Assembly intermedi-
ate with NDUFAF2 highlighted, viewed as in (B); compare fig. S13.
 o
n
 July 23, 2020
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Parey et al., Sci. Adv. 2019; 5 : eaax9484     11 December 2019
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
6 of 10
for a Q substrate in the access pathway. NDUFA12 is the cornerstone 
of the membrane arm/matrix arm interface, and its two surface 
helices are critical for the unusual lipid arrangement in complex I 
(figs. S8 and S9). We propose that binding of NDUFAF2 instead of 
NDUFA12 prevents formation of the native interface structure and, 
thus, restricts Q access before the assembly process is completed. 
This would minimize the risk of ROS formation by reverse electron 
flow from reduced Q to an incomplete electron transfer chain.
We previously found that the EPR signal of FeS cluster N4 
(Fig. 1) was absent in the assembly intermediate (34). Our maps show 
strong density for the N4 cluster, suggesting that loss of the N4 signal in 
the earlier study was due to a change of chemical environment rather 
than absence of the cluster. In the wild type, the C-terminal Zn- 
binding domain of the deleted subunit NDUFS6 is situated at the 
interface of the N and Q modules, close to the binding site of N4. 
Therefore, we propose that the loss of the EPR signal is due to the 
N4 site being solvent accessible and that the assembly factor has no 
critical role in the insertion of this FeS cluster.
Immunological experiments had suggested that in Neurospora crassa 
NDUFAF2 associates with a complex I subassembly containing the 
central subunits of the Q module (NDUFS2, 3, 7, and 8) but lacking 
the complete N module (29). In agreement with this finding, a recent 
complexome profiling study on the assembly pathway of human 
complex I demonstrated that NDUFAF2 attaches to a subassembly that 
includes part of the membrane arm, ND1, and the central subunits 
of the Q module (38). The N module (including NDUFS1, FV1, and 
FV2) is added later as a separate building block. It has been shown 
that a concerted interplay of NDUFS4, NDUFS6, and NDUFA12 is 
required to release the assembly factor (29, 36). Our cryo-EM struc-
ture (Fig. 5) shows that the C-terminal end of the assembly factor 
anchors the N module to the Q module. Our data therefore concur 
with the concerted action of NDUFA12 and NDUFS6 in complex I 
assembly. The role of NDUFS4 in this process seems to be more 
intricate. NDUFAF2 is associated with complex I in patients carrying 
mutations in NDUFS4 (39). In agreement with an earlier study (29), 
we observed that in mitochondrial membranes, NDUFAF2 remained 
associated with complex I in our ndufs4 strain (12). The assembly 
factor was lost during purification of this mutant protein complex 
but is an integral part of the NDUFS6 mutant structure described 
here. Since NDUFA12 and NDUFS6 assemble in the NDUFS4 
mutant (see above), there must be an additional but weaker attach-
ment site in the absence of NDUFS4, probably at the unoccupied 
position of this subunit. In our structure of the assembly intermediate, 
NDUFS4 is present, and a 102-residue stretch of the assembly factor 
is unresolved. We propose that at least a part of this disordered seg-
ment is displaced by NDUFS4 when the complex assembles. Note 
that an extension of NDUFS4 reaches through a narrow opening 
between NDUFS1 and NDUFS3 to the side of the peripheral arm 
decorated by NDUFAF2 (Fig. 5D). NDUFAF2 binding in this region 
might provide a platform for the attachment of NDUFS1, which is 
then firmly anchored by the C-terminal end of the assembly factor 
(Fig. 6). Once NDUFS1 is in the correct position, NDUFAF2 detaches 
by joint action of NDUFA12, NDUFS4, and NDUFS6. In NDUFS4- 
and NDUFS6-linked diseases, complex I assembly is compromised 
by disturbing the interplay of the three subunits and the assembly 
factor. Moreover, binding of NDUFAF2 to mutant complex I might 
reduce the amount of free assembly factor that is available to support 
a sufficient level of complex I assembly. In our NDUFS6 mutant, NDUFS4 
binds and probably sets the stage for release of NDUFAF2, but the 
assembly factor remains firmly associated with complex I because 
NDUFS6, and therefore the NDUFS6/NDUFA12 tandem, is absent.
In summary, our new high-resolution cryo-EM structure of respira-
tory complex I, together with our large-scale molecular simulations, 
sheds new light on the unique interactions of the 1-MDa membrane 
protein complex with Q and the lipid bilayer of the membrane. 
Cryo-EM structures of complex I variants generated with our yeast 
genetic model system offer clues on the structural basis of NDUFS4-linked 
Leigh syndrome and the function of assembly factor NDUFAF2. 
NDUFAF2 anchors the N module to nascent complex I and is re-
leased by joint action of three accessory subunits. Combining cryo-EM, 
molecular simulations, and yeast genetics opens a new avenue for 
investigating complex I, the most intricate molecular machine of 
the respiratory chain.
MATERIALS AND METHODS
Purification of complex I variants from Y. lipolytica
Complex I was purified from Y. lipolytica strain GB30 carrying a 
deletion for the sulfur transferase (ST1) gene to enhance sample 
homogeneity (40). ST1 is a substoichiometric component of 
Y. lipolytica complex I, and the enzyme complex is fully functional in 
Fig. 6. Function of the assembly factor NDUFAF2. (A) Assembly factor NDUFAF2 
associates with a complex I assembly intermediate that lacks the N module 
(NDUFS1, NDUFV1, and NDUFV2). NDUFAF2 provides a platform for N module attachment 
(dashed line) and anchors NDUFS1 with its C-terminal tail. In the wild type, the con-
certed interplay of NDUFS4, NDUFS6, and NDUFA12 releases NDUFAF2. NDUFS6 
and NDUFA12 form a structural unit that is obligatory for function. (B) In the NDUFS6 
mutant, NDUFS4 can bind and then detaches a part of NDUFAF2 (dotted line), but 
the assembly factor remains firmly bound because NDUFS6 is absent.
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the absence of this polypeptide. Protein purification was carried out 
by His-tag affinity and size exclusion chromatography as described 
in (41), but on the Ni-NTA Sepharose column, the detergent was 
exchanged from 0.025% DDM to 0.025% LMNG. The complex I 
assembly intermediate accumulating in the numm strain (34) 
(NUMM corresponds to NDUFS6; see table S2) was purified in the 
same way and polished by ion exchange chromatography on a 
MonoQ column. The complex I mutant from strain nuym (12) 
(NUYM corresponds to NDUFS4; see table S2) was purified in the 
same way as the GB30 complex but without the detergent exchange.
Activity measurements
NADH:decylubiquinone (DBQ) oxidoreductase activity was measured in 
20 mM Na+-Mops (pH 7.2), 50 mM NaCl, 2 mM KCN, and 0.025% 
LMNG using 150 M DBQ and 100 M NADH as substrates. The 
residual activity in the presence of 2 M 2-n-decyl-quinazolin-4-yl-
amine (DQA) was subtracted. For assignment of our preparation to 
the A or D form, we tested the sensitivity of complex I toward 5 mM 
MgCl2 or 2 mM NEM. Activity measurements were carried out in 
50 mM tris-HCl (pH 8.5), 80 mM KCl, 0.2 mM EDTA, 1.1 mM NaCN, 
and 0.025% LMNG with 150 M DBQ and 100 M NADH (9).
Proton pumping assay with reconstituted complex I
Asolectin (10 mg ml−1) from soybean was solubilized in 1.6% 
n-octyl glucopyranoside, 20 mM K+-Mops (pH 7.2), and 80 mM KCl. 
Purified complex I (200 g) was reconstituted into proteoliposomes 
at a protein-to-lipid ratio of 1:50 (w/w) according to (42), but 
with 30-min intervals for the addition of BioBeads (Bio-Rad). 
Proteoliposomes were centrifuged at 100,000g (1 hour, 4°C) and 
resuspended in 200 l of 20 mM K+-Mops (pH 7.2) and 80 mM 
KCl. Proteoliposomes containing 5 g of complex I were added to 
2 ml of buffer [20 mM K+-Mops (pH 7.2), 50 mM KCl, and 0.5 M 
valinomycin] in a stirred cuvette. Proton pumping was monitored 
by ACMA fluorescence quenching. The fluorophore was added to a 
final concentration of 0.5 M. Measurements were performed in a 
Shimadzu RF-5001 fluorimeter at an excitation wavelength of 
430 nm and an emission wavelength of 475 nm (bandpass, 5 nm 
each; integration time, 1 s) at 30°C. The reaction was started by the 
successive addition of 60 M DBQ and 100 M NADH. Last, 1 M 
FCCP was added to collapse the pH gradient.
Mass spectrometry
Purified complex I from Y. lipolytica was denatured in 2 M guanidine 
hydrochloride. Proteins were digested with trypsin (sequencing grade, 
Promega) and analyzed by mass spectrometry using Thermo Scientific Q 
Exactive Plus equipped with an ultra-high performance liquid chroma-
tography (UHPLC) unit (Thermo Scientific Dionex UltiMate 3000). 
Peptides and proteins (false discovery ratio, <0.01) were identified 
by PEAKS Studio 7.0 (Bioinformatics Solutions Inc.) using all 6456 
entries of Y. lipolytica from UniProtKB (released in July 2016) sup-
plemented with the information of YALI1_D30003p.
Sample extraction for lipid mass spectrometry
Lipid and Q9 were extracted with minor modification as described 
(43). Briefly, 1.5 ml of methanol containing 5 nmol phosphatidyletha-
nolamine (PE) 24:0 as extraction control standard and 5 ml of methyl 
tert-butyl ether (MTBE) were added to the Y. lipolytica protein pellets. 
After shaking, addition of 1.25 ml of deionized water, and centrifu-
gation, the upper organic phase was collected and the lower aqueous 
phase was extracted a second time with MTBE/methanol/water 
(10/3/2.5, v/v/v). The combined organic extracts were dried in a 
stream of nitrogen and redissolved in 500 l of chloroform/methanol 
(1/1, v/v). Twenty-five microliters of this extract was supplemented with 
0.2 nmol phosphatidylcholine (PC) 25:0, 17:4, 43:6, and 31:1; 0.3 nmol 
PE 25:0, 37:4, 43:6 and 31:1; 0.3 nmol phosphatidylserine (PS) 25:0, 37:4, 
43:6, and 31:1; 0.135 nmol lysophosphatidylcholine 17:1; 0.2 nmol 
phosphatidylinositol 25:0, 37:4, 43:6, and 31:1; 0.89 nmol CL 57:4; 
0.81 nmol CL 61:1; 0.71 nmol CL 80:4; 0.68 nmol CL 86:4 (all lipid 
species are quantitative LM standards from Avanti Polar Lipids, USA); 
and 5 nmol Coenzyme Q10 (Merck, Germany), evaporated and re-
dissolved in 100 l of isopropanol/chloroform/methanol (95/5/5, v/v/v).
Reverse-phase liquid chromatography  
mass spectrometry analysis
Phospholipid and ubiquinone were quantified as described (44). 
For chromatographic separation, a BEH C8 reversed-phase column 
(100 mm by 1 mm, 1.7 m) from Waters (Waters, USA) was used at 
a column oven temperature of 50°C in a Dionex UltiMate 3000 RS 
UHPLC system (Thermo Fisher Scientific Inc., USA). Gradients 
were eluted with 50% eluent A, containing 1% of 1 M aqueous 
ammonium formate and 0.1% formic acid, raising to 100% eluent B, 
containing acetonitrile/isopropanol (5/2 v/v) with the same additives, 
over 40 min, followed by 10 min at 100% eluent B. The flow rate was 
set to 150 l min−1, and the autosampler temperature was 8°C.
For ionization and analysis, an Orbitrap Velos Pro Mass Spectrometer 
(Thermo Fisher Scientific Inc., USA) in data-dependent acquisition 
mode with HESI-II ion source was used. Samples were measured in 
positive electrospray mode at 4.5-kV source voltage, 275°C source 
temperature, and 300°C capillary temperature in full scan [mass/
charge ratio (m/z), 320 to 1.000]. In negative electrospray mode, the 
source voltage was at 3.8 kV, the source temperature was at 325°C, 
and the capillary temperature was at 300°C in full scan (m/z 320 
to 1600). Resolution was set at 100,000 (m/z, 400). The 10 most 
abundant ions of the spectrum were sequentially fragmented with 
collision-induced dissociation mode in the ion trap using He as collision 
gas (normalized collision energy, 50; isolation width, 1.5; activation 
Q, 0.2; and activation time, 10). Exclusion time was set at 11 s. Data 
were processed using a Lipid Data Analyzer described in (45) with a 
cutoff filter at 5% quantified with the added internal standards as a 
one-point calibration and normalized to the protein weight. 
Annotation was according to the official LIPID MAPS shorthand 
nomenclature (46).
Cryo-EM sample preparation and imaging
Complex I or assembly intermediate purified in LMNG was applied 
at a concentration of 1.5 to 2 mg/ml to freshly glow-discharged C-flat 
1/1 or 1.2/1.3 holey carbon grids (Protochips, USA). Samples of 
the NDUFS4 mutant, containing DDM as detergent, were diluted 
to a final concentration of 2.7 mg/ml. Grids were automatically 
blotted for 12 to 14 s in a Vitrobot Mark IV (Thermo Fisher Scientific 
Inc., USA) at 10°C and 80% humidity [drain and wait time, 0 s; 
blot force, −2 a.u. (arbitrary units)], plunge frozen in liquid ethane, 
and stored in liquid nitrogen until further use.
Cryo-EM data of wild-type complex I and the assembly intermediate 
were collected automatically on a 300-kV FEI Titan Krios micro-
scope (Thermo Fisher Scientific Inc., USA) using EPU software 
(Thermo Fisher Scientific Inc., USA) on a K2 Summit detector (Gatan) 
in counting mode. Cryo-EM images were acquired at a nominal 
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magnification of ×125,000 with a calibrated pixel size of 1.077 Å 
and a total exposure of 30 to 40 e−/Å2, at defocus ranges from −1.5 
to −2.5 m. Cryo-EM data of the NDUFS4 mutant were collected 
automatically with Leginon (47) on an FEI Tecnai Polara micro-
scope (Thermo Fisher Scientific Inc., USA) at 300 kV equipped with 
a Gatan K2 direct electron detector operating in counting mode. 
Cryo-EM images were acquired at a calibrated pixel size of 1.09 Å 
(nominal magnification of ×200,000), a defocus range from −2.0 
to −3.0 m, an exposure time of 8 s, and a total electron exposure on 
the specimen of ~60 e−/Å2.
Image processing
A set of 4043 dose-fractionated micrographs from wild-type com-
plex I were subjected to motion correction and dose-weighting of 
frames by MotionCor2 (48). The micrograph-based contrast transfer 
function (CTF) was determined by CTFFIND4.1, and the resulting 
images were used for further analysis with the software package 
RELION-3.0 (49). Particles were picked using Autopick within 
RELION-3.0, yielding 666,666 particles, which were extracted with 
a box size of 456 by 456 pixels. Initial reference-free 2D classification 
was performed with fourfold binned data to remove false positives 
and imperfect particles. Visual selection of class averages with inter-
pretable features resulted in a dataset of 664,841 particles, which 
were further sorted by 3D classification with a previous cryo-EM 
map of complex I from Y. lipolytica (8) low-pass filtered to 30 Å as 
an initial reference for the first round of 3D classification. The re-
sulting best 3D class of 297,066 particles was autorefined, yielding a 
map with a 3.5-Å resolution. In a final step, the resolution was improved 
using algorithms for CTF refinement and Bayesian polishing imple-
mented in RELION-3.0 (49). The final map at 3.2-Å resolution was 
sharpened using an isotropic B-factor of −66 Å2 (fig. S1 and table S1). 
Local map resolution was estimated with ResMap (http://resmap.
sourceforge.net) (fig. S2) (50). All resolutions were estimated using 
the 0.143 cutoff criterion (51) with gold standard Fourier shell cor-
relation (FSC) between two independently refined half maps (52).
A similar image processing workflow was applied to the complex I 
assembly intermediate and NDUFS4 mutant. For the assembly 
intermediate, a total of 250,406 particles were extracted from 1386 
motion-corrected micrographs. 3D classification resulted in a final 
dataset of 112,418 particles, which yielded a 3.3-Å map after CTF 
refinement and Bayesian polishing. An isotropic B-factor of −50 Å2 
was applied (fig. S2). For the NDUFS4 mutant, CTF parameters 
were estimated by Gctf within the RELION-3.0 workflow (49). A total 
of 418,740 particles were extracted from 5964 micrographs after 
discarding images that showed contamination or poor CTF estima-
tion. The extracted particles were subjected to reference-free 2D 
classification and sorted by 3D classification. The best class, com-
prising 145,767 particles, was autorefined and CTF refined, and 
Bayesian polishing was applied in RELION-3.0. The final map of 
4.0-Å resolution was sharpened with an isotropic B-factor of −30, 
and the local resolution was estimated with ResMap (fig. S2).
Model building
The cryo-EM structure of deactive Y. lipolytica complex I [Protein 
Data Bank (PDB) ID 6GCS] was used as template for building the 
wild-type complex I in COOT (53). Full-atom models of all accessory 
subunits were built. A previously unidentified density with one TM 
helix fitted the sequence of NUUM, a subunit without homolog in 
mammalian complex I. The density assigned as NUUM in the 
previous map (8) occupies the position of the mammalian subunit 
NDUFB2. A BLAST search in fungi yielded several homologs, in-
cluding one in the yeast Pichia pastoris (Komatagaella phaffii). 
A second BLAST search with this yeast homolog against the Y. lipolytica 
proteome (https://blast.ncbi.nlm.nih.gov) yielded the sequence of 
YALI1_D3003g, which fitted the density. We refer to this previously 
unidentified Y. lipolytica complex I subunit as NIGM. Lipids were 
built wherever possible, and the fatty acid tails truncated to the visible 
density. Two LMNG molecules were identified and built. The struc-
ture was refined using phenix.real_space_refine (54), followed by 
several rounds of rebuilding in COOT. The NDUFS4 and 
NDUFS6 structures were built with the wild-type model as template. 
The model was cross-validated against overfitting by the method as 
described earlier (55): The FSC between the refined model and the 
final map was determined (FSCSUM; fig. S2B). Random shifts (up to 
0.3 Å) were introduced into the coordinates of the final model, 
followed by refinement in PHENIX against the first unfiltered half-
map. Then, the FSC was determined between this refined model 
and the half-map used for refinement (FSCwork), and the FSC 
against the second half-map, which was not used at any point during 
refinement (FSCfree). The marginal gap between the curves describing 
FSCwork and FSCfree indicates that the model was not overfitted (see 
fig. S2B). A quality check indicated excellent stereochemistry with 91.51 to 
93.89% of the nonglycine and nonproline residues found in the most- 
favored regions and with 0.15 to 0.17% outliers (all-atom clashscore, 
8.36 to 9.29). Refinement and validation statistics were summarized in 
Table 1. Figures were drawn with Chimera (56) and PyMOL (The PyMOL 
Molecular Graphics System, Version 2.0, Schrödinger, LLC).
Computational methods
Classical atomistic MD simulations were performed on the entire 
structure of complex I from Y. lipolytica. Three short stretches that 
were missing from the structure (residues 355 to 359 in the NDUFA9 
subunit and residues 77 to 83 and 138 to 151 in the NDUFB11 sub-
unit, respectively) were modeled using the Modeller software (57). 
All structurally resolved lipids, the ligands, and the metal centers 
were included in the model [Q9, flavin mononucleotide (FMN), 
FeS clusters, NADPH, and phosphopantetheine (ZMP)]. The entire 
protein system was embedded into a hybrid lipid bilayer, which was 
generated using CHARMM-GUI (58). The membrane composition 
was tailored to mimic the inner mitochondrial membrane with 50% 
3-palmitoyl-2-oleoyl-D-glycero-1-phosphatidylcholine (POPC), 35% 
3-palmitoyl-2-oleoyl-D-glycero-1-phosphatidylethanolamine (POPE), 
and 15% CL. The protein-membrane complex was then solvated 
with TIP3 water molecules and Na+ and Cl− ions (100 mM). The 
CHARMM36 force field was used for protein, lipids, water, and 
ions (59, 60), and the available force field parameters for oxidized 
Q9 (61), FMN and FeS clusters [see (62)], NADPH (63), and ZMP 
(58). The total system size was about 1.3 million atoms.
GROMACS (2016.4) (64) was used to perform the MD simulations. 
First, the energy of the entire system was minimized to fix the 
geometry of all the components and release strain from the system. 
Furthermore, keeping harmonic restraints on the heavy protein atoms 
(force constant 20,000 kJ mol−1 nm−2) and on the membrane lipid 
phosphates (2000 kJ mol−1 nm−2 force constant in the z direction), 
we ran a short (100 ps) NVT equilibration using velocity-rescaling 
thermostat (65). Subsequently, we performed a 10-ns NPT equilibration 
run with harmonic restraints on the backbone of the protein and on 
heavy atoms of Q9 with the Berendsen barostat (66). In the production 
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MD, all atoms were kept free. The Nose-Hoover thermostat (67, 68) 
and Parrinello-Rahman barostat (69) were applied, keeping the 
temperature at 310 K and a pressure of 1 atmosphere. The time step 
for integration during MD was 2 fs using LINCS (70). Cryo-EM 
structures and simulation trajectories were analyzed with Visual 
Molecular Dynamics (VMD) (71). The total simulation time was ~1 s.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/12/eaax9484/DC1
Supplementary Materials and Methods
Fig. S1. Structure determination of wild-type complex I, assembly intermediate, and mutant 
without NDUFS4.
Fig. S2. Representative cryo-EM densities of wild-type complex I with fitted models.
Fig. S3. Assignment of accessory subunits.
Fig. S4. A second Q binding site in complex I and quantitative mass spectrometry.
Fig. S5. Atomic model of Y. lipolytica complex I in membrane-solvent environment and 
hydrogen bond analysis from MD simulation trajectory.
Fig. S6. Interactions between protein and the Q head group and tail.
Fig. S7. Lipid binding sites in yeast and mammalian complex I.
Fig. S8. Surface helices and lipids modeled at the interface of the membrane arm and the 
peripheral arm.
Fig. S9. Bending of the lipid tails seen in MD simulation.
Fig. S10. Spectrophotometric assay of NADH:DBQ activity.
Fig. S11. Conformation of the 1-2 loop of NDUFS2 and loops and regions critical for the 
active/deactive transition.
Fig. S12. Proton pumping activity of the NDUFS4 mutant.
Fig. S13. Cartoon representation and sequence alignment of NDUFAF2 and NDUFA12 from  
Y. lipolytica and Homo sapiens.
Table S1. Data collection, refinement, and model statistics.
Table S2. Subunit names and chain identifiers for Y. lipolytica and human and bovine complex I.
Table S3. Lipid species detected in Y. lipolytica complex I.
Movie S1. Cryo-EM structure of respiratory complex I from Y. lipolytica in LMNG at 3.2-Å resolution.
Movie S2. Cryo-EM structure of NDUFS4 at 4.0-Å resolution.
Movie S3. Cryo-EM structure of the NDUFS6 assembly intermediate at 3.3-Å resolution.
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